Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Minimum Clinically Important Difference in 30-s Sit-to-Stand Test After Pulmonary Rehabilitation in Subjects With COPD.

Zanini A, Crisafulli E, D'Andria M, Gregorini C, Cherubino F, Zampogna E, Azzola A, Spanevello A, Schiavone N, Chetta A.

Respir Care. 2019 Jul 3. pii: respcare.06694. doi: 10.4187/respcare.06694. [Epub ahead of print]

PMID:
31270178
2.

Hospitalized acute exacerbations of chronic obstructive pulmonary disease: which patients may have a negative clinical outcome?

Crisafulli E, Torres A.

Expert Rev Respir Med. 2019 Jul 3:1-3. doi: 10.1080/17476348.2019.1635459. [Epub ahead of print] No abstract available.

PMID:
31241390
3.

Reduced exercise ventilatory efficiency in Cystic Fibrosis adults with normal to moderately impaired lung function.

Di Paolo M, Teopompi E, Savi D, Crisafulli E, Longo C, Tzani P, Longo F, Ielpo A, Pisi G, Cimino G, Simmonds NJ, Neder JA, Chetta A, Palange P.

J Appl Physiol (1985). 2019 Jun 20. doi: 10.1152/japplphysiol.00030.2019. [Epub ahead of print]

PMID:
31219769
4.

The value of high-resolution computed tomography (HRCT) to determine exercise ventilatory inefficiency and dynamic hyperinflation in adult patients with cystic fibrosis.

Crisafulli E, Teopompi E, Luceri S, Longo F, Tzani P, Pagano P, Ielpo A, Longo C, Di Paolo M, Sverzellati N, Palange P, Chetta A, Pisi G.

Respir Res. 2019 Apr 24;20(1):78. doi: 10.1186/s12931-019-1044-8.

5.

Cough, a vital reflex. mechanisms, determinants and measurements.

Andrani F, Aiello M, Bertorelli G, Crisafulli E, Chetta A.

Acta Biomed. 2019 Jan 15;89(4):477-480. doi: 10.23750/abm.v89i4.6182.

6.

Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study.

Crisafulli E, Ielpo A, Barbeta E, Ceccato A, Huerta A, Gabarrús A, Soler N, Chetta A, Torres A.

Respir Res. 2018 Dec 27;19(1):261. doi: 10.1186/s12931-018-0951-4.

7.

Carfilzomib: a Tale of a Heartbreaking Moment. Case Report and Concise Review of the Literature.

Serra W, Fantin A, Longo C, Rabia G, De Rosa F, Plenteda C, Re F, Crisafulli E, Chetta A.

Cardiovasc Hematol Disord Drug Targets. 2018 Dec 4. doi: 10.2174/1871529X19666181205100705. [Epub ahead of print]

PMID:
30516116
8.

Pleuritis with pleural effusion due to a Bacillus megaterium infection.

Crisafulli E, Aredano I, Valzano I, Burgazzi B, Andrani F, Chetta A.

Respirol Case Rep. 2018 Nov 28;7(1):e00381. doi: 10.1002/rcr2.381. eCollection 2019 Jan.

9.

A High Degree of Dyspnea Is Associated With Poor Maximum Exercise Capacity in Subjects With COPD With the Same Severity of Air-Flow Obstruction.

Crisafulli E, Aiello M, Tzani P, Ielpo A, Longo C, Alfieri V, Bertorelli G, Chetta A.

Respir Care. 2019 Apr;64(4):390-397. doi: 10.4187/respcare.06336. Epub 2018 Nov 13.

PMID:
30425167
10.

Flow and volume response to bronchodilator in patients with COPD.

Vigna M, Aiello M, Bertorelli G, Crisafulli E, Chetta A.

Acta Biomed. 2018 Oct 8;89(3):332-336. doi: 10.23750/abm.v89i3.5631.

11.

Pulmonary hernia: Case report and review of the literature.

Scelfo C, Longo C, Aiello M, Bertorelli G, Crisafulli E, Chetta A.

Respirol Case Rep. 2018 Oct 2;6(8):e00354. doi: 10.1002/rcr2.354. eCollection 2018 Nov.

12.

Management of severe acute exacerbations of COPD: an updated narrative review.

Crisafulli E, Barbeta E, Ielpo A, Torres A.

Multidiscip Respir Med. 2018 Oct 2;13:36. doi: 10.1186/s40248-018-0149-0. eCollection 2018. Review.

13.

Looking for Predictors of Early Readmission in Chronic Obstructive Pulmonary Disease: Every Effort Is Required.

Crisafulli E, Guerrero M, Ielpo A, Chetta A, Torres A.

Ann Am Thorac Soc. 2018 Nov;15(11):1366. doi: 10.1513/AnnalsATS.201807-458LE. No abstract available.

PMID:
30141969
14.

Heart rate recovery is associated with ventilatory constraints and excess ventilation during exercise in patients with chronic obstructive pulmonary disease.

Crisafulli E, Vigna M, Ielpo A, Tzani P, Mangia A, Teopompi E, Aiello M, Alfieri V, Bertorelli G, Palange P, Chetta A.

Eur J Prev Cardiol. 2018 Oct;25(15):1667-1674. doi: 10.1177/2047487318789756. Epub 2018 Jul 23.

PMID:
30033754
15.

Spot the trachea! A wide paratracheal air cyst of not easy definition.

Crisafulli E, Lazzari C, Longo C, Bernardinello N, Alfieri V, Chetta A.

Acta Biomed. 2018 Jun 7;89(2):260-261. doi: 10.23750/abm.v89i2.5610.

16.

Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysis.

Crisafulli E, Guerrero M, Ielpo A, Ceccato A, Huerta A, Gabarrús A, Soler N, Chetta A, Torres A.

Sci Rep. 2018 Jun 18;8(1):9236. doi: 10.1038/s41598-018-27680-y.

17.

Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease.

Estirado C, Ceccato A, Guerrero M, Huerta A, Cilloniz C, Vilaró O, Gabarrús A, Gea J, Crisafulli E, Soler N, Torres A.

Respir Res. 2018 Jun 15;19(1):119. doi: 10.1186/s12931-018-0820-1.

18.

When Two Drugs Are Better than Three: Re-Modulating the Therapeutic Plan of a Chronic Obstructive Pulmonary Disease Patient.

Ielpo A, Crisafulli E.

Respiration. 2018;95 Suppl 1:6-10. doi: 10.1159/000487173. Epub 2018 Apr 27.

19.

COPD 2017: A Year in Review.

Crisafulli E, Torres A.

COPD. 2018 Apr;15(2):118-122. doi: 10.1080/15412555.2018.1444022. Epub 2018 Mar 27. Review.

PMID:
29583021
20.

The role of the microbiome in childhood asthma.

Pisi G, Fainardi V, Aiello M, Bertorelli G, Crisafulli E, Chetta A.

Immunotherapy. 2017 Nov;9(15):1295-1304. doi: 10.2217/imt-2017-0048. Review.

PMID:
29130800
21.

Acute exacerbations of COPD: risk factors for failure and relapse.

Mantero M, Rogliani P, Di Pasquale M, Polverino E, Crisafulli E, Guerrero M, Gramegna A, Cazzola M, Blasi F.

Int J Chron Obstruct Pulmon Dis. 2017 Sep 8;12:2687-2693. doi: 10.2147/COPD.S145253. eCollection 2017. Review.

22.

Next generation beta adrenoreceptor agonists for the treatment of asthma.

Crisafulli E, Frizzelli A, Fantin A, Manco A, Mangia A, Pisi G, Fainardi V, Alfieri V, Aiello M, Bertorelli G, Chetta A.

Expert Opin Pharmacother. 2017 Oct;18(14):1499-1505. doi: 10.1080/14656566.2017.1378348. Epub 2017 Sep 14. Review.

PMID:
28891349
23.

Sarcoidosis in an Italian province. Prevalence and environmental risk factors.

Beghè D, Dall'Asta L, Garavelli C, Pastorelli AA, Muscarella M, Saccani G, Aiello M, Crisafulli E, Corradi M, Stacchini P, Chetta A, Bertorelli G.

PLoS One. 2017 May 5;12(5):e0176859. doi: 10.1371/journal.pone.0176859. eCollection 2017.

24.

Asymptomatic peripheral artery disease can limit maximal exercise capacity in chronic obstructive pulmonary disease patients regardless of airflow obstruction and lung hyperinflation.

Crisafulli E, Scelfo C, Tzani P, Aiello M, Bertorelli G, Chetta A.

Eur J Prev Cardiol. 2017 Jun;24(9):990-999. doi: 10.1177/2047487317695629. Epub 2017 Jan 1.

PMID:
28436723
25.

Prevalence of Small-Airway Dysfunction among COPD Patients with Different GOLD Stages and Its Role in the Impact of Disease.

Crisafulli E, Pisi R, Aiello M, Vigna M, Tzani P, Torres A, Bertorelli G, Chetta A.

Respiration. 2017;93(1):32-41. Epub 2016 Nov 17.

26.

Transthoracic Echocardiography and Chest Computed Tomography Arteriography in Patients with Acute Pulmonary Embolism: A Two-Year Follow-Up Study.

Serra W, Crisafulli E, Sverzellati N, Ugolotti PT, Tzani P, Marangio E, Ardissino D, Gherli T, Chetta A.

Respiration. 2016;92(4):235-240. Epub 2016 Sep 8.

27.

Relationships between emphysema and airways metrics at High-Resolution Computed Tomography (HRCT) and ventilatory response to exercise in mild to moderate COPD patients.

Crisafulli E, Alfieri V, Silva M, Aiello M, Tzani P, Milanese G, Bertorelli G, Sverzellati N, Chetta A.

Respir Med. 2016 Aug;117:207-14. doi: 10.1016/j.rmed.2016.06.016. Epub 2016 Jun 21.

28.

Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?

Crisafulli E, Guerrero M, Chetta A, Torres A.

Eur Respir J. 2016 Jul;48(1):279-81. doi: 10.1183/13993003.00426-2016. No abstract available.

29.

Are interstitial lung abnormalities associated with COPD? A nested case-control study.

Bozzetti F, Paladini I, Rabaiotti E, Franceschini A, Alfieri V, Chetta A, Crisafulli E, Silva M, Pastorino U, Sverzellati N.

Int J Chron Obstruct Pulmon Dis. 2016 May 26;11:1087-96. doi: 10.2147/COPD.S103256. eCollection 2016.

30.

Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.

Bertino G, Privitera G, Purrello F, Demma S, Crisafulli E, Spadaro L, Koukias N, Tsochatzis EA.

Intern Emerg Med. 2016 Oct;11(7):905-16. doi: 10.1007/s11739-016-1478-7. Epub 2016 Jun 7. Review.

PMID:
27273018
31.

Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study.

Guerrero M, Crisafulli E, Liapikou A, Huerta A, Gabarrús A, Chetta A, Soler N, Torres A.

PLoS One. 2016 Mar 4;11(3):e0150737. doi: 10.1371/journal.pone.0150737. eCollection 2016.

32.

Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.

Crisafulli E, Zanini A, Pisi G, Pignatti P, Poli G, Scuri M, Chetta A.

Expert Rev Respir Med. 2016;10(5):481-90. doi: 10.1586/17476348.2016.1161508. Epub 2016 Mar 16. Review.

PMID:
26938578
33.

Predicting In-Hospital Treatment Failure (≤ 7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids.

Crisafulli E, Torres A, Huerta A, Guerrero M, Gabarrús A, Gimeno A, Martinez R, Soler N, Fernández L, Wedzicha JA, Menéndez R.

COPD. 2016;13(1):82-92. doi: 10.3109/15412555.2015.1057276. Epub 2015 Oct 9.

PMID:
26451913
34.

Endotracheal tubes for critically ill patients: an in vivo analysis of associated tracheal injury, mucociliary clearance, and sealing efficacy.

Li Bassi G, Luque N, Martí JD, Aguilera Xiol E, Di Pasquale M, Giunta V, Comaru T, Rigol M, Terraneo S, De Rosa F, Rinaudo M, Crisafulli E, Peralta Lepe RC, Agusti C, Lucena C, Ferrer M, Fernández L, Torres A.

Chest. 2015 May;147(5):1327-1335. doi: 10.1378/chest.14-1438.

PMID:
25500677
35.

C-Reactive Protein at Discharge, Diabetes Mellitus and ≥ 1 Hospitalization During Previous Year Predict Early Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Crisafulli E, Torres A, Huerta A, Méndez R, Guerrero M, Martinez R, Liapikou A, Soler N, Sethi S, Menéndez R.

COPD. 2015 Jun;12(3):306-14. doi: 10.3109/15412555.2014.933954. Epub 2014 Oct 3.

PMID:
25279441
36.

Inhaled corticosteroids do not influence the early inflammatory response and clinical presentation of hospitalized subjects with COPD exacerbation.

Crisafulli E, Guerrero M, Menéndez R, Huerta A, Martinez R, Gimeno A, Soler N, Torres A.

Respir Care. 2014 Oct;59(10):1550-9. doi: 10.4187/respcare.03036. Epub 2014 Jul 29.

37.

Predicting poor prognosis in COPD patients: looking for a lamp lit in the darkness of the night.

Crisafulli E.

Eur Respir J. 2014 Jun;43(6):1560-2. doi: 10.1183/09031936.00045614. No abstract available.

38.

Rehabilitation and supportive therapy in elderly patients with Chronic Obstructive Pulmonary Disease.

Crisafulli E, Morandi A, Olivini A, Malerba M, Clini EM.

Eur J Intern Med. 2014 Apr;25(4):329-35. doi: 10.1016/j.ejim.2014.01.003. Epub 2014 Jan 25. Review.

PMID:
24472694
39.

Biologic therapy for atopic asthma and beyond.

Caruso M, Crisafulli E, Lizzio R, Polosa R.

Curr Opin Allergy Clin Immunol. 2013 Dec;13(6):677-85. doi: 10.1097/ACI.0000000000000012. Review.

PMID:
24152740
40.

Assessment of severity of ICU-acquired pneumonia and association with etiology.

Di Pasquale M, Ferrer M, Esperatti M, Crisafulli E, Giunta V, Li Bassi G, Rinaudo M, Blasi F, Niederman M, Torres A.

Crit Care Med. 2014 Feb;42(2):303-12. doi: 10.1097/CCM.0b013e3182a272a2.

PMID:
23989176
41.

Respiratory muscle training in patients recovering recent open cardiothoracic surgery: a randomized-controlled trial.

Crisafulli E, Venturelli E, Siscaro G, Florini F, Papetti A, Lugli D, Cerulli M, Clini E.

Biomed Res Int. 2013;2013:354276. doi: 10.1155/2013/354276. Epub 2013 Jul 30.

42.

Impact of chronic liver disease in intensive care unit acquired pneumonia: a prospective study.

Di Pasquale M, Esperatti M, Crisafulli E, Ferrer M, Bassi GL, Rinaudo M, Escorsell A, Fernandez J, Mas A, Blasi F, Torres A.

Intensive Care Med. 2013 Oct;39(10):1776-84. doi: 10.1007/s00134-013-3025-6. Epub 2013 Aug 2.

PMID:
23907496
43.

Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics.

Huerta A, Crisafulli E, Menéndez R, Martínez R, Soler N, Guerrero M, Montull B, Torres A.

Chest. 2013 Oct;144(4):1134-1142. doi: 10.1378/chest.13-0488.

PMID:
23828375
44.

Adenosine signaling pathways as potential therapeutic targets in respiratory disease.

Caruso M, Alamo A, Crisafulli E, Raciti C, Fisichella A, Polosa R.

Expert Opin Ther Targets. 2013 Jul;17(7):761-72. doi: 10.1517/14728222.2013.795220. Epub 2013 May 4. Review.

PMID:
23642090
45.

Predicting walking-induced oxygen desaturations in COPD patients: a statistical model.

Crisafulli E, Iattoni A, Venturelli E, Siscaro G, Beneventi C, Cesario A, Clini EM.

Respir Care. 2013 Sep;58(9):1495-503. doi: 10.4187/respcare.02321. Epub 2013 Jan 29.

46.

Diagnosis of chronic obstructive pulmonary disease, simpler is better. Complexity and simplicity.

Clini EM, Crisafulli E, Roca M, Malerba M.

Eur J Intern Med. 2013 Apr;24(3):195-8. doi: 10.1016/j.ejim.2012.12.009. Epub 2013 Jan 9. No abstract available.

PMID:
23312965
47.

Disabling inflammatory pathways with biologics and resulting clinical outcomes in severe asthma.

Caruso M, Crisafulli E, Demma S, Holgate S, Polosa R.

Expert Opin Biol Ther. 2013 Mar;13(3):393-402. doi: 10.1517/14712598.2013.743989. Epub 2013 Jan 7. Review.

PMID:
23289846
48.

Do we now have a 'couch potato' blood test?

Crisafulli E, Mannino DM.

Respiration. 2013;85(3):193-4. doi: 10.1159/000345380. Epub 2012 Dec 19. No abstract available.

49.

Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD.

Crisafulli E, Menéndez R, Huerta A, Martinez R, Montull B, Clini E, Torres A.

Chest. 2013 Apr;143(4):1009-1017. doi: 10.1378/chest.12-1684.

PMID:
23187314
50.

Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO® project: a multicentre randomized controlled trial.

Venturelli E, Crisafulli E, DeBiase A, Righi D, Berrighi D, Cavicchioli PP, Vagheggini G, Dabrosca F, Balbi B, Paneroni M, Bianchi L, Vitacca M, Galimberti V, Zaurino M, Schiavoni G, Iattoni A, Ambrosino N, Clini EM.

Clin Rehabil. 2013 Apr;27(4):336-46. doi: 10.1177/0269215512458940. Epub 2012 Sep 11.

PMID:
22967853

Supplemental Content

Loading ...
Support Center